Weapons developer Boeing leases space from MIT in the Kendall Square neighborhood of Cambridge, MA.

As Hakeem Angulu from the Harvard College Open Data Project (HODP) reports, Harvard currently owns a staggering 9.56 percent of the total land area of the city of Cambridge. 

BioMed Realty Trust, Inc. is an international real estate firm which owns some of the most expensive properties in the Cambridge MA area. As of 2011, BioMed Realty owns the 320 Bent Street facility that "comprises approximately 184,400 rentable square feet of laboratory and office space which is approximately 79% leased to Merck & Co., Inc."

Co-founded by Eric Lander, an MIT/Harvard professor, Millennium/Takeda has licensed various "intellectual property" products from MIT. Millennium Pharmaceuticals/Takeda Oncology builds on MIT-owned land, contributing to to the rapid rise of housing, rental, and living costs in Cambridge which is driving out the city's working class residents, disproportionately Black and Brown.

Novartis leases buildings from MIT in Cambridge MA.

MIT currently leases a 500,000 square foot building to Pfizer in the Kendall Square neighborhood of Cambridge, MA.

BioMed Realty Trust, Inc. is a real estate firm which owns some of the most expensive properties in the Cambridge area.. As of 2011, BioMed owns the 301 Binney Street building that has "approximately 417,300 rentable square feet of office and laboratory space," a portion of which is leased to the Broad Institute of Harvard and MIT. BioMed Realty has also leased space to big pharma companies like Merck.